Rakta Therapeutics, Inc.
Rockville, MD
- UEI
- G43JQMRR5JL5
- CAGE
- 6Y5T3
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 9610 Medical Center Dr #295, Rockville, MD 20850, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Selective inhibitors of heme transporters as antiparasitic agents | National Institute of Allergy and Infectious Diseases (NIH) | $702,314 |
Quick answers
Is Rakta Therapeutics, Inc. registered in SAM.gov?
Yes. Rakta Therapeutics, Inc.'s SAM.gov registration is active through May 10, 2027.
What is Rakta Therapeutics, Inc.'s most recent federal award?
Rakta Therapeutics, Inc.'s most recent federal grant award is Selective inhibitors of heme transporters as antiparasitic agents (R41AI113998), from National Institute of Allergy and Infectious Diseases (NIH), on February 1, 2015.
On GovTribe
See Rakta Therapeutics, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors